Cel-Sci
CVM
#9847
Rank
โ‚ฌ37.63 M
Marketcap
4,48ย โ‚ฌ
Share price
1.94%
Change (1 day)
-60.14%
Change (1 year)

Cel-Sci (CVM) - Cash on Hand

Cash on Hand as of September 2025 : โ‚ฌ9.33 Million

According to Cel-Sci 's latest financial reports the company has โ‚ฌ9.33 Million in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Cel-Sci - Cash on Hand chart (from 1996 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2025-09-30โ‚ฌ9.33 M119.37%
2024-09-30โ‚ฌ4.25 M8.64%
2023-09-30โ‚ฌ3.91 M-83.1%
2022-09-30โ‚ฌ23.17 M-36.46%
2021-09-30โ‚ฌ36.46 M175.74%
2020-09-30โ‚ฌ13.22 M70.71%
2019-09-30โ‚ฌ7.74 M-12.79%
2018-09-30โ‚ฌ8.88 M340.23%
2017-09-30โ‚ฌ2.01 M-22.49%
2016-09-30โ‚ฌ2.6 M-49.21%
2015-09-30โ‚ฌ5.12 M-23.97%
2014-09-30โ‚ฌ6.74 M21812.59%
2013-09-30โ‚ฌ0.03 M-99%
2012-09-30โ‚ฌ3.07 M-1.99%
2011-09-30โ‚ฌ3.13 M-83.9%
2010-09-30โ‚ฌ19.5 M-15.66%
2009-09-30โ‚ฌ23.12 M3456.84%
2008-09-30โ‚ฌ0.65 M-91.58%
2007-09-30โ‚ฌ7.72 M20.99%
2006-09-30โ‚ฌ6.38 M291.8%
2005-09-30โ‚ฌ1.62 M-52.57%
2004-09-30โ‚ฌ3.43 M127.74%
2003-09-30โ‚ฌ1.5 M-28.83%
2002-09-30โ‚ฌ2.11 M-18.9%
2001-09-30โ‚ฌ2.61 M-78.45%
2000-09-30โ‚ฌ12.12 M118.76%
1999-09-30โ‚ฌ5.54 M-47.38%
1998-09-30โ‚ฌ10.53 M257.14%
1997-09-30โ‚ฌ2.94 M0%
1996-09-30โ‚ฌ2.94 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Curis
CRIS
โ‚ฌ7.71 M-17.37%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
โ‚ฌ0.18 B 1,843.42%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚ฌ8.05 B 86,128.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Xencor
XNCR
โ‚ฌ0.40 B 4,200.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
โ‚ฌ1.87 B 20,012.29%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Johnson & Johnson
JNJ
โ‚ฌ15.82 B 169,361.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
โ‚ฌ0.20 B 2,141.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
โ‚ฌ2.59 M-72.18%๐Ÿ‡บ๐Ÿ‡ธ USA